Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Food and Drug Administration (FDA) announced that the shortage of semaglutide injections had been resolved, leading to the removal of these products from the agencys drug shortage list
The Sanyal Phase 2a in MASLD examined 98 adults with metabolic dysfunction-associated steatotic liver disease and 10 percent liver fat content, randomised to retatrutide or placebo over 48 weeks
Tandem Mass Spectral Library. NIST
After a simple online intake and a virtual consultation with a licensed medical provider, a personalized treatment plan is created
Retatrutide is an investigational pharmaceutical agent currently under clinical development and does not hold a marketing authorisation from the MHRA or the European Medicines Agency (EMA)
US$ 20.16
US$ 22.17
US$ 23.41
US$ 25.88
